<DOC>
	<DOCNO>NCT01939444</DOCNO>
	<brief_summary>The overall aim pilot study give preliminary estimation key parameter pharmacokinetics proper formulation intranasal naloxone . These data use design well justified protocol final estimation parameter : - Preliminary estimation bioavailability intranasal naloxone human , healthy volunteer - Preliminary estimation maximum serum concentration ( Cmax ) formulation - Preliminary estimation time maximum serum concentration ( Tmax ) formulation - Safety formulation</brief_summary>
	<brief_title>A Pilot Study Bioavailability Nasal Naloxone</brief_title>
	<detailed_description />
	<mesh_term>Drug Overdose</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>healthy ( adequate organ function determine electrocardiogram ( ECG ) , liver kidney clinical chemistry , standard clinical examination/interview . For safety reason may ask urine sample analysis opioids ) inform consent history liver disease take medication include herbal medicine last week history drug abuse local nasal disease nasal surgery recent cold last week history drug allergy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Antidotes</keyword>
	<keyword>naloxone</keyword>
	<keyword>administration , intravenous</keyword>
	<keyword>administration , intranasal</keyword>
	<keyword>pharmacology</keyword>
</DOC>